Bidisciplinary dermatology-pharmacovigilance consultations: Results of a two-year study

Ann Dermatol Venereol. 2023 Sep;150(3):217-218. doi: 10.1016/j.annder.2022.08.011. Epub 2022 Dec 7.

Authors

P Sanchez-Pena¹, B Milpied², A-S Darrigade², G Miremont-Salamé³, A Pariente³, M Beylot Barry²

Affiliations

¹ Pharmacovigilance center, University Hospital of Bordeaux, Bordeaux, France. Electronic address: [email protected].
² Dermatology Department, University Hospital of Bordeaux, Bordeaux, France.
³ Pharmacovigilance center, University Hospital of Bordeaux, Bordeaux, France; Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, Bordeaux, France.

PMID: 36496263
DOI: 10.1016/j.annder.2022.08.011

No abstract available

Keywords: Acute generalised exanthematous pustulosis; Cutaneous adverse-drug reaction; DRESS syndrome; Exanthema; Pharmacovigilance.

Publication types

Letter

MeSH terms

Acute Generalized Exanthematous Pustulosis*
Anti-Bacterial Agents
Dermatology*
Drug Eruptions*
Exanthema*
Humans
Pharmacovigilance
Referral and Consultation

Substances

Anti-Bacterial Agents